Phase 1 study results of selinexor combination therapy; multiple myeloma

Go to article

Posted by on June 6, 2016 6:28 pm
Tags:
Categories: health

Researchers have completed a phase 1 study of selinexor in combination with liposomal doxorubicin and dexamethasone in patients with relapsed and refractory multiple myeloma.

Leave a Reply

Your email address will not be published. Required fields are marked *

< Buzz Post home